Shares in Bruker BioSciences gained 11.4 percent over the past three weeks, leading the 11 firms whose shares rose during the three-week trading period ended Tuesday (Note: BioCommerce Week did not publish the past two weeks). Bio-Rad posted the next-largest increase with a gain of 6.8 percent.
 
Stratagene slumped again to a new 52-week low to close at $4.70 on Tuesday, down 14.4 percent for the three-week period.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.